Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-Acetylcysteine for Prevention of Cisplatin-induced Nephrotoxicity
NCT06019520Unknown
- Sponsor
- Foundation University Islamabad
- Start
- Aug 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of acetylcysteine in cisplatin-induced nephrotoxicity (CIN), sponsored by Foundation University Islamabad. Primary endpoint: Serum creatinine at 18 weeks. Status: unknown.
02
Drugs
acetylcysteine
03
Conditions
cisplatin-induced nephrotoxicity (CIN)
Beyond the preview
Go deeper on NCT06019520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06019520.